SCHEMBL6874926

SCHEMBL6874926

CCCCCCC[C@@H](C)OC(=O)c1ccc(OC(=O)c2ccc3cc(C(=O)Oc4ccc(C(=O)O[C@H](C)CCCCCCC)cc4)ccc3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ TSHR P16473 1/20 0.48
▸ NPC1 O15118 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ NFKB1 P19838 3/20 0.47
▸ NFKB2 Q00653 3/20 0.47
▸ RELA Q04206 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ MGLL Q99685 1/20 0.44
▸ MAPT P10636 6/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ PRSS1 P07477 1/20 0.43
▸ ACR P10323 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9799447 0.93 NPC1 (0.53) ALDH1A1TSHRNPC1LMNANFKB1
SCHEMBL9458665 0.92 ALDH1A1 (0.57) ALDH1A1TSHRMAPTKMT2AKDM4E
SCHEMBL9458305 0.92 ALDH1A1 (0.57) ALDH1A1TSHRMAPTKMT2AKDM4E
SCHEMBL9799608 0.91 TSHR (0.54) TSHRNPC1LMNANFKB1NFKB2
SCHEMBL9779497 0.91 TSHR (0.54) TSHRNPC1LMNANFKB1NFKB2
SCHEMBL9799611 0.91 TSHR (0.54) TSHRNPC1LMNANFKB1NFKB2
SCHEMBL9458329 0.91 ALDH1A1 (0.55) ALDH1A1TSHRMAPTKMT2AKDM4E
SCHEMBL6872611 0.90 ALDH1A1 (0.52) ALDH1A1TSHRNPC1LMNANFKB1
SCHEMBL6872017 0.90 ALDH1A1 (0.52) ALDH1A1TSHRNPC1LMNANFKB1
SCHEMBL12408695 0.89 ALDH1A1 (0.51) ALDH1A1TSHRNPC1LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821581-B2 ESTER DERIVATIVES OF TEREPHTHALIC ACID ESTERS; HAVE A HELICAL TWISTING POWER OF AT LEAST 9; HELICAL PITCH INDUCED DECREASES IN LENGTH WITH AN INCREASE IN TEMPERATURE. MITSUBISHI GAS CHEMICAL CO., INC. (JP) 2004-11-23 — — US disclosed
US-20030124268-A1 Optically active compound and liquid crystal composition containing the compound MITSUBISHI GAS CHEMICAL CO., INC. 2003-07-03 — — US disclosed
EP-1270542-A1 Optically active compound and liquid crystal composition containing the compound MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124268-A1 Optically active compound and liquid crystal composition containing the compound CRY1, CRY2, PNP ALDH1A1 4498/4885TSHR 4000/4885NPC1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback